Woman Man
- | Country :
- Canada
- Hungary
- France
- The 5 others...
- | organs : -
- | Specialty : -
Extract
The purpose of this trial is to study the efficacy of a 35 mg delayed release weekly dosing regimen as compared to the standard daily dosing regimen of risedronate 5 mg daily.
Inclusion criteria
- Postmenopausal osteoporosis